Precigen, Inc. (PGEN)

NASDAQ: PGEN · Real-Time Price · USD

5.64

+0.39 (7.43%)

At close: Jul 2, 2026, 4:00 PM EDT

5.60

-0.04 (-0.71%)

After-hours: Jul 2, 2026, 7:54 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology (Startups)	9.68M	3.93M	6.23M	-	-
Biotechnology (Startups) Growth	146.73%	-36.95%	-	-	-
Exemplar	-	-	-	12.02M	13.35M
Exemplar Growth	-	-	-	-9.97%	31.37%
Biopharmaceuticals	-	-	-	14.89M	922.00K
Biopharmaceuticals Growth	-	-	-	1515.40%	-96.53%
Total	9.68M	3.93M	6.23M	26.91M	14.27M
Total Growth	146.73%	-36.95%	-76.87%	88.61%	-55.40%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States of America	9.68M	3.93M	6.23M	26.68M	13.89M
United States of America Growth	146.73%	-36.95%	-76.66%	92.07%	-55.76%
Foreign Countries	-	-	-	233.00K	378.00K
Foreign Countries Growth	-	-	-	-38.36%	-36.47%
Total	9.68M	3.93M	6.23M	26.91M	14.27M
Total Growth	146.73%	-36.95%	-76.87%	88.61%	-55.40%